TW264384B - - Google Patents

Info

Publication number
TW264384B
TW264384B TW82106135A TW82106135A TW264384B TW 264384 B TW264384 B TW 264384B TW 82106135 A TW82106135 A TW 82106135A TW 82106135 A TW82106135 A TW 82106135A TW 264384 B TW264384 B TW 264384B
Authority
TW
Taiwan
Application number
TW82106135A
Other languages
Chinese (zh)
Original Assignee
Hyal Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002094203A external-priority patent/CA2094203A1/en
Application filed by Hyal Pharma Corp filed Critical Hyal Pharma Corp
Application granted granted Critical
Publication of TW264384B publication Critical patent/TW264384B/zh

Links

TW82106135A 1993-04-16 1993-07-31 TW264384B (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002094203A CA2094203A1 (en) 1993-04-16 1993-04-16 Inhibition of angiogenesis

Publications (1)

Publication Number Publication Date
TW264384B true TW264384B (cs) 1995-12-01

Family

ID=51402059

Family Applications (1)

Application Number Title Priority Date Filing Date
TW82106135A TW264384B (cs) 1993-04-16 1993-07-31

Country Status (1)

Country Link
TW (1) TW264384B (cs)

Similar Documents

Publication Publication Date Title
EP0690955A4 (cs)
DK22893A (cs)
DK0618680T3 (cs)
EP0647920A3 (cs)
EP0707697A4 (cs)
EP0641839A3 (cs)
DK0648636T3 (cs)
EP0661739A3 (cs)
DK21494A (cs)
TW264384B (cs)
ECSDI930104S (cs)
ECSDI930155S (cs)
DK91593D0 (cs)
ECSDI930107S (cs)
ECSDI930119S (cs)
ECSDI930120S (cs)
ECSDI930135S (cs)
ECSDI930138S (cs)
ECSDI930145S (cs)
ECSDI930099S (cs)
ECSDI930157S (cs)
ECSDI930159S (cs)
DK52193D0 (cs)
DK143893D0 (cs)
DK121693D0 (cs)